Esperion Therapeutics
ESPR
#6169
Rank
$0.88 B
Marketcap
$3.73
Share price
-1.58%
Change (1 day)
11.68%
Change (1 year)

Esperion Therapeutics (ESPR) - Total assets

Total assets on the balance sheet as of September 2025 : $0.36 Billion USD

According to Esperion Therapeutics's latest financial reports the company's total assets are $0.36 Billion USD. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Esperion Therapeutics - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2024-12-31$0.34 B67.07%
2023-12-31$0.20 B-17%
2022-12-31$0.24 B-35.02%
2021-12-31$0.38 B8.02%
2020-12-31$0.35 B64.73%
2019-12-31$0.21 B49.49%
2018-12-31$0.14 B-48.37%
2017-12-31$0.27 B13.3%
2016-12-31$0.24 B-17.04%
2015-12-31$0.29 B106.3%
2014-12-31$0.14 B83%
2013-12-31$78.29 M970.7%
2012-12-31$7.31 M235.47%
2011-12-31$2.17 M
2002-12-31$51.4 M-34.38%
2001-12-31$78.34 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Ultragenyx Pharmaceutical
RARE
$1.19 B 227.03%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
$7.61 B 1,991.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
$208.73 B 57,240.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
$40.16 B 10,934.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
$0.86 B 138.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
$0.20 B-43.43%๐Ÿ‡บ๐Ÿ‡ธ USA